UiPath Inc.: Charting The Path Towards Enterprise Automation

UiPath hits an inflection point with stabilizing SaaS, AI roadmap, Maestro platform upsells, top partnerships, and clean ...

Liquidia: Yutrepia's Attributes In Focus, But Binary Risk Shouldn't Be Ignored

Liquidia Corporation remains a Buy for risk-tolerant biotech investors, supported by strong Yutrepia launch metrics and ...